Valuation Ipsen

Stocks

Market Closed - Euronext Paris Other stock markets 16:55:00 09/07/2026 BST			Pre-market 07:12:37
168.80 ^EUR	+1.69%		168.60	-0.12%

07-09	Wall Street Ignores the Sirens
07-09	Ipsen Reports Positive Topline Phase III Results for Dysport in Both Episodic and Chronic Migraine	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	13,858	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	41.85%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	12,433	11,431	10,594
Change	-	16.81%	12.22%	1.81%	2.28%	34.77%	-8.06%	-7.32%
P/E	10.4x	12.9x	14x	26.7x	22.4x	15.3x	15x	15x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.76x	2.33x	2.01x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	8.78x	31.89x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	3.24x	3.08x	2.95x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.91x	2.54x	2.26x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	7.41x	6.73x	6.3x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	8.62x	7.75x	7.18x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	11.3x	9.97x	9.04x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	8.85%	10%	11.1%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.509	1.497	1.596
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.89%	0.89%	0.95%
EPS ²	7.76	7.81	7.73	4.15	5.32	11.04	11.23	11.28
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	13.7%	13.3%	14.1%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,276	4,495	4,690
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,678	1,699	1,682
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,442	1,475	1,476
Net income ¹	646.6	647.5	647.2	347.3	444.5	944.9	949.5	948.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,426	-2,428	-3,265
Reference price ²	80.50	100.50	107.90	110.70	119.00	168.80	168.80	168.80
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	82,100	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPSEN	15.29x	2.91x	7.41x	0.89%	15.84B
ELI LILLY AND COMPANY	35.49x	12.92x	26.31x	0.56%	1,085B
JOHNSON & JOHNSON	27.65x	6.35x	17.24x	2.06%	624B
ABBVIE INC.	30.17x	7.39x	15.12x	2.74%	442B
ROCHE HOLDING AG	17.88x	4.44x	10.99x	2.98%	332B
ASTRAZENECA PLC	22.38x	4.7x	13.12x	1.86%	277B
NOVARTIS AG	21.53x	5.52x	13.36x	2.86%	282B
NOVO NORDISK A/S	14.08x	5.27x	10.83x	3.55%	217B
AMGEN INC.	23.79x	6.31x	11.13x	2.77%	196B
GILEAD SCIENCES, INC.	-47.8x	5.8x	32.25x	2.41%	167B
Average	16.04x	6.16x	15.78x	2.27%	363.78B
Weighted average by Cap.	23.98x	7.96x	18.44x	1.96%